Abstract
Imipenem combined with cilastatin and meropenem was given as intravenous infusions of 1 g to eight young, healthy males on two separate occasions. Blood and urine samples were collected for up to 12 h. The terminal half-lives in plasma were 0.98 h and 1.11 h for meropenem and imipenem, respectively. The volume of distribution was smaller for meropenem than for imipenem (12.5 l and 14.4 l, respectively). The plasma clearance for meropenem was 188 (SD 31) ml/min and for imipenem 183 (SD 25) ml/min. Renal clearance was on average 139 (SD 24) ml/min and 135 (SD 11) ml/min, respectively. About 75% of the administered dose of both compounds was eliminated unchanged in urine. Non-renal clearance accounted for approximately 25% of the total clearance for both drugs. The kinetics of meropenem are very similar to those of imipenem given with cilastatin, and meropenem is as stable against renal metabolic degradation as imipenem combined with cilastatin.
Similar content being viewed by others
References
Jones RN, Barry AL, Thornsberry C In vitro studies of meropenem. Journal of Antimicrobial Chemotherapy 1989, 24, Supplement A: 9–29.
Kayser FH, Morenzoni G, Strässle A, Hadorn K Activity of meropenem against gram-positive bacteria. Journal of Antimicrobial Chemotherapy 1989, 24, Supplement A: 101–112.
Nord CE, Lindmark A, Persson I Susceptibility of anerobic bacteria to meropenem. Journal of Antimicrobial Chemotherapy 1989, 24, Supplement A: 113–117.
Harrison MP, Moss SR, Featherstone A, Fowkes AG, Sanders AM, Case DE The disposition and metabolism of meropenem in laboratory animals and man. Journal of Antimicrobial Chemotherapy 1989, 24, Supplement A: 265–277.
Bax RP, Bastain W, Featherstone A, Wilkinson DM, Hutchison M, Haworth SJ The pharmacokinetics of meropenem in volunteers. Journal of Antimicrobial Chemotherapy 1989, 24, Supplement A: 311–320.
Krutzén, Bäck SE, Nilsson-Ehle I, Nilsson-Ehle P Plasma clearance of a new contrast agent, iohexol: a method for the assessment of glomerular filtration rate. Journal of Laboratory and Clinical Medicine 1984, 104: 955–961.
Gibaldi M, Perrier D Pharmacokinetics. Marcel Dekker, New York, 1982, p. 409.
Topham JC, Murgatroyd LB, Jones DV, Gonnetilleke URP, Wright J Safety evaluation of meropenem in animals: studies on the kidney. Journal of Antimicrobial Chemotherapy 1989, 24, Supplement A: 287–306.
Norrby SR Imipenem/cilastatin: Rationale for a fixed combination. Reviews of Infectious Diseases 1985, 7, Supplement 3: 447–451.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nilsson-Ehle, I., Hutchison, M., Haworth, S.J. et al. Pharmacokinetics of meropenem compared to imipenem-cilastatin in young, healthy males. Eur. J. Clin. Microbiol. Infect. Dis. 10, 85–88 (1991). https://doi.org/10.1007/BF01964413
Issue Date:
DOI: https://doi.org/10.1007/BF01964413